Ua ʻae hou ʻia ʻo Veyong no ʻelua mau lāʻau lapaʻau holoholona Class II hou

ʻO Tadilosin kahi lāʻau antibiotic cyclohexanide 16 i hoʻolaʻa ʻia i nā holoholona semisynthetic, a ua like kona hopena antibacterial me ka tylosin, ka mea e pale nui ai i ka elongation kaulahao peptide a kāohi i ka synthesis o nā protein bacteria ma ka hoʻopaʻa ʻana i ka subunit 50S o ka ribosome bacteria.Loaʻa iā ia ka laulā antibacterial ākea a he hopena bacteriostatic i ka maikaʻi a me kekahi mau bacteria maikaʻi ʻole, ʻoi aku ka maʻalahi i nā pathogens respiratory, e like me Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, a me Streptococcus suis.
I kēia manawa, ʻo ka pilikia nui e kū nei i ka ʻoihana hānai holoholona ma ka honua holoʻokoʻa ka nui o ka maʻi maʻi a me ka make o nā maʻi hanu, me nā poho waiwai i hoʻokumu ʻia e nā maʻi hanu e like me ke kiʻekiʻe o nā haneli miliona o ka makahiki.Hiki i ka Tadiluoxin injection ke hāʻawi i ke ʻano holoʻokoʻa o ka mālama ʻana no ka pale ʻana a me ka mālama ʻana i nā maʻi maʻi hanu i hoʻokumu ʻia e ka maʻi bacteria maʻemaʻe i loko o nā puaʻa, a he hopena therapeutic maopopo loa i nā maʻi hanu i nā puaʻa.He nui nā pono e like me ka hoʻohana holoholona kūikawā, ka liʻiliʻi o ka dosage, ke ʻano holoʻokoʻa o ka mālama ʻana me ka hoʻokele hoʻokahi, hoʻopau lōʻihi i ka hapalua o ke ola, bioavailability kiʻekiʻe a me ke koena haʻahaʻa.